RBR-9d8z6m进行中（未招募）3 期
Open and controlled trial of hydroxychloroquine and azytromicyn use to prevent complications in patients infected by new coronavirus (COVID-19): a randomized controlled trial - Brazil COVID Coalition I Trial
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 —（—）
入选标准
- •Patients admitted to the ICU or Hospital with suspected or confirmed COVID-19
排除标准
- •Presence of any of the following: Need to supplement oxygen more than 4L; Use of high flow nasal catheter; Use of non-invasive ventilation; Use of mechanical ventilation; Use of hidroxichoroquine, chloroquine,
- •azithromycin or other macrolide over 24 hours; History of severe ventricular or QTC equal or grater than 48 ms cardiac arrithmia; History of hepatic desease (cirrosis); Renal dysfunction (estimated glomerular filtration rate [eGFR] less than 30ml/min/1.73m2, using MDRD or CKD-EPI method); Patients with retinopathy or macular degeneration; Children under 18 years;Pregnancy; Allergy to chloroquine and derivatives; Allergy to azythromicyn; Patients in hospital over 48hr; Patients with symptoms over 14 days
研究者
相似试验
进行中（未招募）
1 期
Trial of hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care settingCovid-19 infectionEUCTR2020-002038-33-FIPorin kaupunki600
进行中（未招募）
1 期
Randomized controlled trial of hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of elderly COVID-19 PatientsCoronavirus diseaseEUCTR2020-001482-37-DEniversity Hopsital Tuebingen350
进行中（未招募）
1 期
Systematic study of the medicine hydroxychloroquine against placebo for the treatment of adult patients with acute coronavirus disease 2019 – COVID-19Acute coronavirus disease 2019MedDRA version: 20.1Level: PTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2020-001224-33-DEniversitätsklinikum Tübingen220
已完成
不适用
A randomized controlled trial of hydroxychloroquine prophylaxis for Healthcare Workers exposed to COVID-19CTRI/2020/05/025067George Institute for Global Health India416
尚未招募
不适用
An observational study on QT interval changes with Hydroxychloroquine used as prophylaxis in COVID exposure risk individualsCTRI/2020/05/025289P Vamsavardhana Reddy